Prevention

Preventive measures in patients with primary biliary cirrhosis are reduced to the prevention of disease progression.

For this purpose, treatment of the disease must begin at stage I (stage of inflammation) or, in extreme cases, stage II (stage of progressive inflammation).

In the late stages of the disease, when liver cirrhosis and portal hypertension have developed , preventive measures should be aimed at preventing bleeding from varicose veins. For this purpose, all patients with cirrhosis of the liver undergo esophagogastroduodenoscopy.

If the risk of bleeding is high, then the patient should be prescribed beta-blocker therapy. With intolerance to these drugs, sclerotherapy or ligation of varicose veins is carried out. Subsequently, repeated examinations are carried out every 6 months.

If the sizes of varicose veins are small, then a re-examination is carried out after 2-3 years to assess the dynamics of the progression of the pathological process.

If the patient has no varicose veins, then re-examination is carried out after 3-5 years.